Matrix metalloproteinases (MMPs) have an important role in many biological processes, such as tumor metastasis, wound healing, and inflammation. The regulation of MMPs and their inhibitors is still not known in detail, and the aim of this study was to investigate the effects of dexamethasone on cultured oral benign and malignant cell lines. The expression of MMPs in culture was studied: in four gingival (GF) and one periodontal ligament (PLF) fibroblast cell lines; in six gingival keratinocyte (GK) cell lines; and in UNR (UNR-108, Rat Osteogenic sarcoma) and SCC (SCC-25, Human Tonque Squamous Cell Carcinoma) cell lines. In the GFs, PLFs, and UNR cells, only MMP-2 (72 kDa gelatinase) was detected by gelatin zymography, while in most of the GK cell lines only MMP-9 (92 kDa gelatinase) was observed. In confluent SCC cultures, both MMP-2 and MMP-9 were found, while only MMP-2 was seen in rapidly growing SCC cells, demonstrating that cell proliferation influenced gelatinase expression in these cells, but not in the other cell lines studied. Dexamethasone at concentrations of 10-5 mol/L and 10-7 mol/L decreased the production of gelatinases in the GFs and PLFs, but not in the GKs, SCC, or UNR cells. The expression of mRNAs for matrix metalloproteinases (MMP-1 [interstitial collagenase] and MMP-2) and their inhibitors (TIMP-1 and TIMP-2) was also studied in the GFs by Northern hybridization. Dexamethasone markedly decreased the amount of MMP-2 mRNA in the GFs. The mRNA level of MMP-1 decreased even more in the same GFs. The mRNA levels for TIMP-1 and TIMP-2 were also decreased by dexamethasone in the GFs. Cell proliferation influenced the degree to which dexamethasone decreased these mRNA levels. The results indicate that glucocorticoids decrease the levels of MMPs and TIMPs in oral fibroblastic cells, whereas they do not appear to affect the production of gelatinases in either normal or malignant oral epithelial cell lines.
Albini A., Melchiori A., Santi L., Liotta LA, Brown PD, Stetler-Stevenson WG (1991). Tumor cell invasion inhibited by TIMP-2. Reports . J Natl Cancer Inst83:775-779.
2.
Apte SS, Mattei M.-G, Olsen BR (1994). Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics19:86-90.
3.
Bauer EA, Kronberger A., Valle K-J., Jeffrey JJ, Eisen AZ (1985). Glucocorticoid modulation of collagenase expression in human fibroblast cultures: evidence for pre-translational inhibition. Biochim Biophys Acta825:227-235. Birkedal-Hansen H., Moore Wgi, Bodden MK, Windsor LJ, Birkedal-Hansen B., DeCarlo A., et al. (1993). Matrix metalloproteinases: A review. Crit Rev Oral Biol Med4:197-250. Chen J-M., Aimes RT, Ward GR, Youngleib GL, Quigley JP (1991). Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in rous sarcoma virus-transformed chicken embryo fibroblasts. J Biol Chem266:5113-5121.
4.
Chomczynski P., Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem162:156-159.
5.
Clark SD, Kobayashi DK, Welgus HG (1987). Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest80:1280-1288.
6.
Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. (1988). H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem263:6579-6587.
7.
Cutroneo KR, Rokowski R., Counts DF (1981). Glucocorticoids and collagen synthesis: comparison of in vivo and cell culture studies. Collagen Rel Res1:557-568.
8.
Docherty Ajp, Lyons A., Smith BJ, Wright EM, Stephens PE, Harris Tjr, et al. (1985). Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature318:66-69.
9.
Emonard H., GrimaudJ-A.1990). Matrix metalloproteinases. A review. Cell Molec Biol36:131-153.
10.
Fessler LI, Duncan KG, Fessler JH, Salo T., Tryggvason K. (1984). Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem259:9783-9789.
11.
Fields GB, Netzel-Arnett SJ, Windsor LJ, Engler JA, Birkedal-Hansen H., Van Wart HE (1990). Proteolytic activities of human fibroblast collagenase: hydrolysis of a broad range of substrates at a single active site. Biochemistry29:6670-6677. Goldberg GI, Wilhelm SM, Kronberger A., Bauer EA, Grant GA, Eisen AZ (1986). Human fibroblast collagenase. Complete
12.
primary structure and homology to an oncogene transformation-induced rat protein . J Biol Chem261:6600-6605. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S., He CS (1989). Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA86:8207-8211. Goldberg GI, Strongin A., Collier IE, Genrich LT, Marmer BL (1992). Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem267:4583-4591.
13.
Griffith BH (1966). The treatment of keloids with triamicinolone acetonide . Plast Reconstr Surg38:202-208.
14.
Hamalainen L., Oikarinen J., Kivirikko KI (1985). Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of cortisol. J Biol Chem260:720-725.
15.
Heussen C., Dowdle EB (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem102:196-202.
16.
Howard EW, Bullen EC, Banda MJ (1991a). Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem266:13064-13069. Howard EW, Bullen EC, Banda MJ (1991b). Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem266:13070-13075. Kalebic T., Garbisa S., Glaser B., Liotta LA (1983). Basement membrane collagen: Degradation by migrating endothelial cells. Science221:281-283.
17.
Kueng W., Silber E., Eppenberger U. (1989). Quantification of cells cultured on 96-well plates . Anal Biochem182:16-19. Liotta LA, Steeg PS, Stetler-Stevenson WG (1991 ). Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Review. Cell64:327-336.
18.
Matrisian LM (1990). Metalloproteinases and their inhibitors in matrix remodeling. Reviews. Trends Genet6:121-125. McGuire MB, Murphy G., Reynolds JJ, Russell Rgg (1981). Production of collagenase and inhibitor (TIMP) by normal, rheumatoid and osteoarthritic synovium in vitro: Effects of hydrocortisone and indomethacin. Clin Sci61:703-710. Moll UM, Youngleib GL, Rosinski KB, Quigley JP (1990). Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res50:6162-6170.
19.
Mullins DE, Rohrlich ST (1983). The role of proteinases in cellular invasiveness . Biochim Biophys Acta695:177-214. Murphy G., Reynolds JJ, Bretz U., Baggiolini M. (1982). Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analyses of their actions on soluble and insoluble collagens. Biochem J203:209-221. Murphy G., McAlpine CG, Poll CT, Reynolds JJ (1985). Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta831:49-58.
20.
Murphy G., Cockett MI, Ward RV, Docherty Ajp (1991). Matrix metalloproteinase degradation of elastin, type IV collagen
21.
and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J277:277-279.
22.
Nagase H., Ogata Y., Suzuki K., Enghild JJ, Salvesen G. (1991). Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans19:715-718.
23.
O'Grady RL, Nethery A., Hunter N. (1984). A fluorescent screening assay for collagenase using collagen labeled with 2-methoxy-2,4-diphenyl-3(2H)-furanone. Anal Biochem140:490-494.
24.
Oikarinen A. (1992). Dermal connective tissue modulated by pharmacologic agents. Review. Int J Dermatol31:149-156. Oikarinen KS, Seppa ST (1987). Effect of preservation medium on proliferation and collagen biosynthesis of periodontal ligament fibroblasts. Endod Dent Traumatol3:95-99. Oikarinen A., Salo T., Ala-Kokko L., Tryggvason K. (1987). Dexamethasone modulates the metabolism of type IV collagen and fibronectin in human basement-membrane-forming fibrosarcoma (HT-1080) cells. Biochem J245:235-241. Oikarinen A., Vuorio E., Vuorio T. (1989). Comparison of the effects of dexamethasone and 13-cis-retinoic acid on connective tissue biosynthesis in human skin fibroblasts. Arch Dermatol Res281:273-278.
25.
Reponen P., Sahlberg C., Munaut C., Thesleff I., Tryggvason K. (1994). High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol124:1091-1102.
26.
Salo T., Oikarinen J. (1985). Regulation of type IV collagen degrading enzyme by cortisol during human skin fibroblast growth. Biochem Biophys Res Commun130:588-595.
27.
Salo T., Liotta LA, Tryggvason K. (1983). Purification and characterization of a murine basement membrane collagen degrading enzyme secreted by metastatic tumor cells . J Biol Chem258:3058-3063.
28.
Salo T., Turpeenniemi-Hujanen T., Tryggvason K. (1985). Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J Biol Chem260:8526-8531.
29.
Salo T., Lyons JG, Rahemtulla F., Birkedal-Hansen H., Larjava H. (1991). Transforming growth factor-β1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem266:11436-11441.
30.
Schmid TM, Mayne R., Jeffrey JJ, Linsenmayer TF (1986). Type X collagen contains two cleavage sites for a vertebrate collagenase. J Biol Chem261:4184-4189.
31.
Seltzer JL, Horan TP, Eisen AZ (1983). Regulation of gelatinase in human skin organ cultures by glucocorticoids. J Invest Dermatol80:42-43.
32.
Seltzer JL, Eisen AZ, Bauer EA, Morris NP, Glanville RW, Burgeson RE (1989). Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem264:3822-3826. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG (1991). Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem266:7870-7875. Sottrup-Jensen L., Birkedal-Hansen H. (1989). Human fibroblast collagenase-a-macroglobulin interactions. Localization of
33.
cleavage sites in the bait regions of five mammalian a-macroglobulins. J Biol Chem264:393-401.
34.
Stetler-Stevenson WG (1990). Type IV collagenases in tumor invasion and metastasis . Cancer Metastasis Rev9:289-303. Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989). Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem264:17374-17378.
35.
Stetler-Stevenson WG, Brown PD, Onisto M., Levy AT, Liotta LA (1990). Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem265:13933-13938.
36.
Tezuka K., Nemoto K., Tezuka Y., Sato T., Ikeda Y., Kobori M., et al. (1994). Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem269:15006-15009.
37.
Uria JA, Ferrando AA, Velasco G., Freije Jmp, Lopez-Otin C. (1994). Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res54:2091-2094.
38.
Vuorio T., Makela JK, Kahari V-M., Vuorio E. (1987). Coordinated
39.
regulation of type I and type III collagen production and mRNA levels of proal(I) and proa2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res279:154-160. Welgus HG, Fliszar CJ, Seltzer JL, Schmid TM, Jeffrey JJ (1990). Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase. J Biol Chem265:13521-13527.
40.
Werb Z. ( 1978). Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase and plasminogen activator secretion and effects on other metabolic functions. J Exp Med147:1695-1712. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI (1989). SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem264:17213-17221.
41.
Wucherpfennig AL, Li Y-P., Stetler-Stevenson WG, Rosenberg AE, Stashenko P. (1994). Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J Bone Miner Res9:549-556.
